Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
09/2009
09/01/2009CA2376691C Antipsychotic cyclic n-aralkylamines
09/01/2009CA2370556C Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof
09/01/2009CA2367368C Carbamic acid derivatives and their use as metabotropic glutamate receptor ligands
09/01/2009CA2308216C Use of non-immunosuppressive compounds for promoting nerve regeneration
09/01/2009CA2210812C T-cell affecting peptides
08/2009
08/27/2009WO2009105712A1 Heterocyclic compounds and compositions as c-kit and pdgfr kinase inhibitors
08/27/2009WO2009105680A2 Genetic polymorphisms associated with stroke, methods of detection and uses thereof
08/27/2009WO2009105641A2 Preventing and treating amyloid-beta deposition by stimulation of innate immunity
08/27/2009WO2009105510A1 Methods for using rapamycin analogues in the treatment of neurological disorders
08/27/2009WO2009105507A2 Beloxepin, its enantiomers, and analogs thereof for the treatment of pain
08/27/2009WO2009105206A1 Modulators of the histamine h3 receptor useful for the treatment of disorders related thereto
08/27/2009WO2009105026A1 Compound (r) -n*6*-ethyl-6, 7-dihydro-5h-indeno (5, 6- d) thiazole-2, 6-diamine and the use as antipsychotics
08/27/2009WO2009104990A1 2,4-diaminopyridine derivatives, a pharmaceutical composition and a medicinal agent which are based thereon and used for treating or preventing diseases and disturbances caused by the hyperactivation of nmda-receptors and/or in the form of cognitive function stimulators and a method for the use thereof
08/27/2009WO2009104739A1 Solid preparation for oral administration
08/27/2009WO2009104736A1 Antibody having affinity for amyloid plaque in tissue, and pharmaceutical composition comprising the same
08/27/2009WO2009104729A1 Amide derivative and pharmaceutical composition containing the same
08/27/2009WO2009104556A1 Composition
08/27/2009WO2009104388A1 Prophylactic/therapeutic agent for collagenosis
08/27/2009WO2009104155A1 2-aza-bicyclo[2.2.1]heptane derivatives
08/27/2009WO2009103950A1 Fluorinated pyridin-4-0nes
08/27/2009WO2009103932A1 Use of a cardiac glycoside and/or a diuretic for the treatment of neuropathic pain
08/27/2009WO2009103898A1 Peptide derived from neurotensin receptor 3 and use thereof in the treatment of psychiatric diseases
08/27/2009WO2009103652A1 Modulators for amyloid beta
08/27/2009WO2009103626A1 4, 5-dihydro-oxazol-2-yl amine derivatives
08/27/2009WO2009103552A1 Substituted indole derivatives
08/27/2009WO2009103487A1 Use of compounds binding to the sigma receptor ligands for the treatment of neuropathic pain developing as a consequence of chemotherapy
08/27/2009WO2009103312A1 Ezrin, serpin b5, peroxiredoxin-2 and heat shock protein beta-1 as autoantigens for psoriasis and poststreptococcal diseases
08/27/2009WO2009103176A1 Nitrogen-containing bycyclic compounds active on chronic pain conditions
08/27/2009WO2009103166A1 Treatment of neural diseases or conditions
08/27/2009WO2009103150A1 Method for treating migraine headaches
08/27/2009WO2009103105A2 Mimotope
08/27/2009WO2009083738A3 Rna delivery vehicles
08/27/2009WO2009082038A3 Ampa receptor antagonists and zonisamide for epilepsy
08/27/2009WO2009071957A3 Novel peptides and amino acid derivatives, pharmaceutical compositions containing same and the use of these compounds
08/27/2009WO2009061906A3 Treating protein misfolding diseases
08/27/2009WO2009047303A3 Metabotropic glutamate receptor modulators for the treatment of pervasive developmental disorder
08/27/2009WO2009046453A9 Use of neuregulin-1 in reducing brain damage
08/27/2009WO2009043922A3 Extracellular targets for alzheimer's disease
08/27/2009WO2009033811A3 Therapeutic uses of muroctasin and kisspeptin13 and compositions thereof
08/27/2009WO2009033760A3 Use of fibronectin fragment (196-203 ) as a therapeutic agent
08/27/2009WO2009033668A3 Use of a peptide as a therapeutic agent
08/27/2009WO2009033667A3 Use of a peptide as a therapeutic agent
08/27/2009WO2007143231A3 Methods of treating pain and inflammation in neuronal tissue using il-31 antagonists
08/27/2009US20090217392 Anti- integrin antibodies, compositions, methods and uses
08/27/2009US20090217391 T1r3 a novel taste receptor
08/27/2009US20090215995 isolated nucleic acids encoding B7-related polypeptides, including BSL3, which modulate cells that are important for immune and inflammatory responses, such as T-cells
08/27/2009US20090215904 Colchicine compositions and methods
08/27/2009US20090215895 Therapeutic and carrier molecules
08/27/2009US20090215890 Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers
08/27/2009US20090215870 Compositions and methods for targeting of viral vectors
08/27/2009US20090215858 such as Pentylcarbamic acid 5-oxo-2,3,4,5-tetrahydrobenzo[b]thiepin-4-ylmethyl ester, having a high affinity for vanilloid receptors and/or cannabinoid receptors, used as analgesics or for the treatment of neuropathic pain
08/27/2009US20090215850 Method for treating cb2 receptor mediated pain
08/27/2009US20090215842 Method of Treating Schizophrenia Prodrome
08/27/2009US20090215841 D2 Receptor Ligand-078
08/27/2009US20090215822 Substituted Oxadiazole Derivatives as Positive Allosteric Modulators of Metabotropic Glutamate Receptors
08/27/2009US20090215820 Novel alkyl substituted piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
08/27/2009US20090215815 Neurotrophin antagonist compositions
08/27/2009US20090215814 Method of inhibiting neurotrophin-receptor binding
08/27/2009US20090215809 crystalline calcium (3S)-{[(1R)-isobutanoyloxyethoxy]carbonylaminomethyl}-5-methyl-hexanoate hydrate; sustained release oral dosage formualtion with opioid agonist, selective serotonin re-uptake inhibitor and noradrenaline re-uptake inhibitor; an inflammatory disease, neuropathic pain, anxiety, psychosis
08/27/2009US20090215805 4-Heteroaryl Pyrimidine Derivatives and use thereof as Protein Kinase Inhibitors
08/27/2009US20090215801 Novel 2-Aminopyrimidinone Derivatives And Their Use
08/27/2009US20090215796 Compositions, Kits and Methods for a Titration Schedule for Pardoprunox Compounds
08/27/2009US20090215795 Cyclic amidine derivatives
08/27/2009US20090215791 New therapeutic use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-d]pyrimidine
08/27/2009US20090215790 Substituted Oxindole Derivatives, Medicaments Containing the Latter and Use Thereof
08/27/2009US20090215787 Preparations of new polymorphic forms of varenicline tartrate
08/27/2009US20090215782 Use of PDE-5 Inhibitors for Endothelial Repair of Tissues Impaired by Trauma or Disease
08/27/2009US20090215771 Jun N-terminal kinase inhibitors; 1H-pyrrolo[2,3-b]pyridines 3-substituted with a C 5-7 carbocycle and 5-substituted by a 5-member heterocycle; 3-(p-(dimethylamino)phenyl)-5-(2-thiazolyl-1H-pyrrolo[2,3-b]pyridine; neurodegenerative disorders related to apoptosis and/or inflammation
08/27/2009US20090215759 Modulators for amyloid beta
08/27/2009US20090215753 Topical Compositions for Paediatric Use
08/27/2009US20090215752 Compounds, preparation and therapeutic use thereof
08/27/2009US20090215751 Use of Selective Chloride Channel Modulators to Treat Alcohol and/or Stimulant Substance Abuse
08/27/2009US20090215745 Association of a sinus node If current inhibitor and a calcium inhibitor, and pharmaceutical compositions containing it
08/27/2009US20090215736 inhibitors of apoptosis and IL-1 beta secretion; mediate cell apoptosis and inflammation; good cell penetration and pharmacokinetic properties; [3S/R(2S)]3-[2-(Carbazol-9-yl-2-oxo-ethyl)-pentanoylamino]-5-fluoro-4-oxo-pentanoic acid
08/27/2009US20090215725 Substituted 4-aminocyclohexane derivatives
08/27/2009US20090215714 Pyrimidines, such as cytidine, in treatments for patients with biopolar disorder
08/27/2009US20090215705 Alpha 7 Nicotinic Receptor Selective Ligands
08/27/2009US20090215687 Compounds for Enhancing Hypoxia Inducible Factor Activity and Methods of Use
08/27/2009US20090215679 Disease-associated proteins
08/27/2009US20090215672 Cys-Rich, Cell Surface Glycoproteins
08/27/2009US20090215065 Diagnosis and treatment of Hereditary Spastic Paraplegia
08/27/2009US20090214677 Pharmaceutical Composition Containing an Extract of a Solidago Species
08/27/2009US20090214675 4-Chromenonyl-1,4-dihydropyridinecarbonitriles and the use thereof
08/27/2009US20090214650 Methods of Treating alcoholism and alcohol related disorders using combination drug therapy and swellable polymers
08/27/2009US20090214612 Extracellular tnf inhibitors for treating cns disorders
08/27/2009US20090214564 Anti-ephrinb2 antibodies and methods using same
08/27/2009US20090214555 Proteoglycan Splice Variants as Therapeutics and Diagnostics for Amyloid Diseases
08/27/2009US20090214554 Truncated memapsin 2 compositions and treatments
08/27/2009US20090214532 ANKTM1, A Cold-Activated TRP-Like Channel Expressed in Nociceptive Neurons
08/27/2009US20090214515 Methods of preparation of recombinant forms of human beta-amyloid protein and uses of these proteins
08/27/2009US20090214492 Isolated stromal cells for use in the treatment of diseases of the central nervous system
08/27/2009US20090214487 Use of mesenchymal stem cells for treating genetic diseases and disorders
08/27/2009US20090214473 Combination chaperonin 10 and beta-interferon therapy for multiple sclerosis
08/27/2009US20090214470 Eye-drop vaccine containing copolymer 1 for therapeutic immunization
08/27/2009CA2750762A1 Treatment of neural diseases or conditions
08/27/2009CA2716368A1 Genetic polymorphisms associated with stroke, methods of detection and uses thereof
08/27/2009CA2716270A1 Substituted indole derivatives
08/27/2009CA2716230A1 Nitrogen-containing bycyclic compounds active on chronic pain conditions
08/27/2009CA2716215A1 Compound (r) -n*6*-ethyl-6, 7-dihydro-5h-indeno (5, 6- d) thiazole-2, 6-diamine and the use as antipsychotics
08/27/2009CA2716007A1 Mimotope
1 ... 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 ... 1833